Prenatal diagnosis of Walker-Warburg syndrome due to compound mutations in the B3GALNT2 gene

J Gene Med. 2022 May;24(5):e3417. doi: 10.1002/jgm.3417. Epub 2022 Apr 6.

Abstract

Background: Congenital hydrocephalus is one of the symptoms of Walker-Warburg syndrome that is attributed to the disruptions of the genes, among which the B3GALNT2 gene is rarely reported. A diagnosis of the Walker-Warburg syndrome depends on the clinical manifestations and the whole-exome sequencing after birth, which is unfavorable for an early diagnosis.

Methods: Walker-Warburg Syndrome was suspected in two families with severe fetal congenital hydrocephalus. Whole-exome sequencing and Sanger sequencing were performed on the affected fetuses.

Results: The compound heterozygous variants c.1A>G p.(Met1Val) and c.1151+1G>A, and c.1068dupT p.(D357*) and c.1052 T>A p.(L351*) in the B3GALNT2 gene were identified, which were predicted to be pathogenic and likely pathogenic, respectively. Walker-Warburg syndrome was prenatally diagnosed on the basis of fetal imaging and whole-exome sequencing.

Conclusions: Our findings expand the spectrum of pathogenic mutations in Walker-Warburg syndrome and provide new insights into the prenatal diagnosis of the disease.

Keywords: B3GALNT2; Walker-Warburg syndrome; congenital hydrocephalus; prenatal diagnosis; whole-exome sequencing.

MeSH terms

  • Exome Sequencing
  • Female
  • Humans
  • Hydrocephalus*
  • Mutation
  • N-Acetylgalactosaminyltransferases* / genetics
  • Pregnancy
  • Prenatal Diagnosis
  • Walker-Warburg Syndrome* / diagnosis
  • Walker-Warburg Syndrome* / genetics
  • Walker-Warburg Syndrome* / pathology

Substances

  • B3GALNT2 protein, human
  • N-Acetylgalactosaminyltransferases